Previous 10 | Next 10 |
4 Penny Stocks to Watch Into The End Of The Month July has been a wild month for penny stocks . To think that some of the names we’ve discussed were once trading under $1 and now trade above $7 might seem crazy. But to be honest, this is a reoccurring trend among penny stocks. While th...
Unusual Volume Can Mean Something For Penny Stocks; What Does It Mean For These? How do you find penny stocks to buy ? Some people look for things like news. Other people invest in penny stocks with stronger fundamentals. While many traders look at things like chart patterns and technical ind...
SAN DIEGO, July 01, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that, on July 1, 2020, USWM, LLC (“USWM” or “US WorldMeds”) began promoting Adamis’ SYMJEPI ® (epinephrine) Injection 0.3mg and SYMJEP...
SAN DIEGO, June 18, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today the publication of an article entitled “Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl comp...
Adamis Pharmaceuticals ( ADMP +7.7% ) inks an an agreement with Matrix Biomed for global rights to Tempol for the treatment of respiratory diseases, including COVID-19, in addition to a dermatology indication: preventing radiation dermatitis in patients undergoing treatment for cancer. ...
SAN DIEGO, June 15, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today a license to commercialize Tempol, a novel patented investigational drug for the treatment of Coronavirus (COVID-19). The license includes ...
SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today the publication of an article entitled “An open-label, randomized, single-dose, two-period, two-treatment crossover bioavailability study compari...
Once again, I find myself debating on whether to dump my Adamis Pharmaceuticals ( ADMP ) shares or to hold onto them in hopes the company can turn things around. The company reported another disappointing earnings report that revealed a miss on EPS and revenue. Admittedly, the company's poor Q...
Adamis Pharmaceuticals Corporation (ADMP) Q1 2020 Earnings Conference Call May 18, 2020, 05:00 PM ET Company Participants Dennis Carlo - President and CEO Robert Hopkins - CFO Ronald Moss - Chief Medical Officer David Marguglio - Chief Business Officer Conference Call Partic...
Adamis Pharmaceuticals (NASDAQ: ADMP ): Q1 GAAP EPS of -$0.15 misses by $0.08 . More news on: Adamis Pharmaceuticals Corporation, Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Adamis Pharmaceuticals Corporation Company Name:
ADMP Stock Symbol:
NASDAQ Market:
Adamis Pharmaceuticals Corporation Website:
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the company changed its name to DMK Pharmaceuticals Corporation in order to better reflect its new strategic focus on advancing sm...
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2023, and provided an update on recent corporate developments. Q2 2023 ...
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering of 5,930,000 units, with each unit consisting of one share of common stock (or pre-funded warrant in...